Farallon Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Farallon Capital Management LLC
CRD #107322
SEC #801-51763
CIK #0000909661
AUM 52.08 B (2026-03-30)
Employees 355 (36% Investors, 0% Brokers)
Fees
Minimum
Phone415-421-2132
AddressOne Maritime Plaza
San Francisco, CA 94111
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($B)
604836241201999200820172027
In the News
Tue, 30 Jun 2026 Farallon Capital Management LLC Increases Stake in Centessa Phar — GuruFocus
Wed, 24 Jun 2026 Farallon Capital Management Discloses Investment in Centessa with 6.1% Stake — TradingView
Fees and Compensation — Form ADV Part 2A (3/30/2026) [Brochure]
Item 5: Fees and Compensation

A. Fees and Compensation

Management Fees

Management fees payable to Farallon vary by Farallon Fund and are established pursuant to
the Farallon Funds’ respective constituent documents. Management fees charged to the
Farallon Funds typically are calculated as a percentage of capital under management (except
with respect to certain Farallon Funds structured as designated-term private investment funds
where management fees may be based on capital commitments or invested capital), generally
range up to 1.0% per annum, but in certain cases are higher, and are typically payable and
deducted from the assets of each such Farallon Fund quarterly in advance. From time to time,
management fees may be paid to a Farallon Adviser as set forth in the relevant investment
management agreement or constituent document of a Farallon Fund.

Management fees based on capital under management will generally be prorated for any
subscriptions or withdrawals by an investor that are effective other than as of the first or last
day of the quarter. In the event of a distribution or withdrawal prior to the end of a quarter,
Farallon will reimburse to the respective Farallon Fund a pro rata share of such management
fees charged with respect to the distributed or withdrawn amount.

Management fees for any managed account are established pursuant to any such managed
account’s investment management agreement.

Farallon has waived or reduced and may, in the future, waive or reduce management fees for
certain classes or investors, including employees and affiliates of Farallon as well as their
family members and trusts or other entities established for the benefit of such persons or their
families, in its discretion.

Incentive Compensation

Incentive fees payable to Farallon or incentive allocations allocable to FPLLC vary by Farallon
Fund and are established pursuant to the Farallon Funds’ respective constituent documents.
For most open-ended Farallon Funds, incentive fees and incentive allocations generally are
charged at year-end (or on an intra-year withdrawal date, if applicable) at a rate of 20% of net
annual profits to such Farallon Fund, or to capital accounts maintained by such Farallon Funds
for their investors. For this purpose, with respect to investments that are not Special
Investments (as defined below), net profits generally include both realized gains and losses and
unrealized appreciation and depreciation of securities held in the Farallon Funds’ portfolios,
and with respect to Special Investments, net profits generally include only realized gains and
losses and not unrealized appreciation and depreciation. For most open-ended Farallon Funds,
incentive allocations generally will be charged at a rate of 10% instead of 20% for periods after
an unrecovered loss year, which is a year over which net losses have been incurred in an
investor’s capital account, until such investor’s capital account has recovered 250% of the net
losses allocated to such account over such year, subject to certain adjustments, e.g., for
withdrawals. One strategy-specific open-ended Farallon Fund charges an incentive allocation

in excess of the return on a specific index (including on negative performance in excess of the
index).

Other Farallon Funds have different arrangements relative to incentive compensation. Certain
investment-specific and strategy-specific closed-end Farallon Funds have distribution
waterfalls whereby FPLLC is entitled to a 20% carried interest only after investors have
received distributions equal to their capital contributions as of the time of distribution. Certain
Farallon Funds have various preferred or threshold return hurdles that must be reached before
FPLLC is entitled to such incentive compensation. Carried interest may be calculated on an
investment-by-investment basis in respect of certain investment-specific Farallon Funds. From
time to time, the carried interest allocable to FPLLC in respect of certain non-U.S. dollar-
denominated investments may be calculated in the applicable foreign currency.

All incentive compensation for managed accounts are subject to negotiation and established
pursuant to each account’s investment management agreement.

Farallon or FPLLC has waived or reduced and may, in the future, waive or reduce incentive
fees and allocations for certain classes or investors, including employees and affiliates of
Farallon, as well as their family members and trusts or other entities established for the benefit
of such persons or their family members. Farallon or FPLLC has also waived or reduced and
may, in the future, waive or reduce in its discretion incentive fees and allocations in respect of
certain investors in connection with certain netting arrangements that they may have across
multiple Farallon Funds.

B. Payment of Fees

Management fees typically are payable quarterly in advance and may be deducted from the
assets of, or distributions payable by, a Farallon Fund, and incentive or performance-based fees
or profit allocations are generally paid or allocated annually (or upon intra-year withdrawal
dates) from the assets of the Farallon Funds or capital accounts maintained for their investors,
or for certain Investment Partnerships which are structured as designated-term private
investment funds, made as a distribution of proceeds or current income when available. Certain
closed-end Farallon Funds also have the ability to call capital for the payment of fees.

C. Additional Fees and Expenses

To the extent permitted under the Farallon Funds’ constituent documents, the Farallon Funds
are obligated to pay for all legal, auditing and accounting fees and expenses, tax preparation
and tax compliance expenses, investment expenses (including, without limitation, the Farallon
Funds’ share of costs and expenses attributable to sourcing, acquiring, evaluating, holding,
...
Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2026) [Brochure]
Item 7: Types of Clients

Farallon provides investment advice to the Farallon Funds, as described above in Item 4,
managing equity capital for institutions such as endowments, foundations, charitable
organizations and state and municipal government entities, and for high net worth individuals.

The constituent documents for each Farallon Fund may set minimum amounts for investment by
prospective investors. Farallon has waived, and reserves the right to modify or waive, the
minimum investment amounts for the Farallon Funds from time to time. Minimum investment
amounts for managed accounts will be determined on a case-by-case basis.
Sector Form 13F Holdings Value ($B)
Revolution Medicines Inc 1.3
Amazon Com Inc 0.9
Microsoft Corp 0.9
Aon Corp 0.8
Bridgebio Pharma Inc 0.7
Protagonist Therapeutics Inc 0.7
Natera Inc 0.6
Exelixis Inc 0.6
Broadcom Inc 0.6
UnitedHealth Group Inc 0.5
View All
Holdings by Sector ($B)
30241812602011201620212027
Type Form D Funds Date Sold AUM
HF Farallon Special Situations Master Fund III Non-US LP [2024-06-10] 964.6 M
Filed 2025-05-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Farallon Special Situations Master Fund III US LP [2024-06-10] 217.4 M
Filed 2025-05-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Farallon Special Situations Master X-VII LP 2023-03-29 268.5 M
HF Farallon Co-Investment Master Fund LP [2022-08-04] 0.1 M 49.8 M
Filed 2025-05-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Farallon Real Estate Institutional Partners IV LP [2022-08-04] 460.7 M
Filed 2022-07-25 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF Farallon Real Estate Partners IV LP [2022-08-04] 200.9 M
Filed 2022-07-25 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF Farallon Special Investment Institutional Partners IV LP [2022-02-14] 104.7 M 100.0 M
Filed 2021-12-17 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
HF Farallon Special Situations Master Credit IX LP 2022-02-14 259.6 M
HF Farallon Healthcare Partners Master LP [2021-08-03] 510.5 M 4,503.8 M
Filed 2025-07-17 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Farallon Capital F5 CC LP 2021-03-30 295.4 M
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 66 52.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.1
Total 67 52.1
By Discretionary
Discretionary 67 52.1
Non-Discretionary 0 0.0
Total 67 52.1
By Non-United States Persons
Non-United States Persons 21.9
United States Persons 30.1
Total 67 52.1
Limited Partners2011 - 2026
New Jersey Division of Investment
Virginia Retirement System
Form D Directors Role # Filings # Firms 2011 - 2026
Grant Jackson Director 175 39
Martin Lang Director 161 31
Russell Burt Director 113 29
David Kim Executive Officer 88 7
Michael Fisch Executive Officer 42 5
Michael Linn Executive Officer 41 4
Daniel Hirsch Executive Officer 29 3
Cameron Hillyer Executive Officer 27 3
Thomas Steyer Executive Officer 21 3
Jason Moment Executive Officer 13 3
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0000909661]
3 [0000909661]
4 [0000909661]
SC 13D [0000909661]
SC 13G [0000909661]
Form 13D/13G Filer Form 13D/13G Subject Filed
Farallon Capital Management LLC Centessa Pharmaceuticals PLC [2026-06-24]
Farallon Capital Management LLC Amyris Inc [2022-02-24]
Farallon Capital Management LLC Swiftmerge Acquisition Corp [2021-12-27]
Farallon Capital Management LLC Khosla Ventures Acquisition Co III [2021-03-31]
Farallon Capital Management LLC Longboard Pharmaceuticals Inc [2021-03-25]
Farallon Capital Management LLC Amyris Inc [2020-08-20]
Farallon Capital Management LLC Broadmark Realty Capital Inc [2019-11-22]
Farallon Capital Management LLC Enanta Pharmaceuticals Inc [2019-09-27]
Farallon Capital Management LLC Dermtech Inc [2019-09-09]
Farallon Capital Management LLC Dermtech Inc [2019-09-06]
View All
Firm Profile (Form ADV)
Discretionary AUM$28.9B
Clients1 (63 non-US)
ServesInstitutional
Fund TypesHedge Fund, Private Equity
LEI87DR6WT2MK1KMGUC7161
Related People Network
47 people file Form D offerings alongside this firm's people.
Form 3/4/5 Subject 2011 - 2026
Fisch Michael B
Fried Richard B
Marblegate Acquisition Corp
Giauque Nicolas
Linn Michael G
Dreyfuss Philip D
Gehani Varun N
Grassland Investors LLC
Patel Rajiv A
Kim David T
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Generation Bio Co GBIO
Common Stock
2020-06-16 Conversion 1,518,819
Generation Bio Co GBIO
Common Stock
2020-06-16 Buy 400,000 $19.00 7,600,000
Generation Bio Co GBIO
Series C Preferred Stock · derivative
2020-06-16 Conversion 2,682,691
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 249,462 $6.72 1,676,385
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 833,845 $6.72 5,603,438
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 915,583 $6.72 6,152,718
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 899,268 $6.72 6,043,081
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 209,577 $6.72 1,408,357
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 2,067,651 $6.72 13,894,615
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 122,006 $6.72 819,880
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 2,648,696 $6.72 17,799,237
Nexvet Biopharma PLC NVET
Ordinary Shares
2016-02-26 Buy 3,007 $3.36 10,104
Nexvet Biopharma PLC NVET
Ordinary Shares
2016-02-26 Buy 3,303 $3.36 11,098
Nexvet Biopharma PLC NVET
Ordinary Shares
2016-02-26 Buy 9,554 $3.36 32,101
Nexvet Biopharma PLC NVET
Ordinary Shares
2016-02-26 Buy 440 $3.36 1,478
Nexvet Biopharma PLC NVET
Ordinary Share
2016-02-26 Buy 3,244 $3.36 10,900
Nexvet Biopharma PLC NVET
Ordinary Shares
2016-02-26 Buy 756 $3.36 2,540
Nexvet Biopharma PLC NVET
Ordinary Shares
2016-02-26 Buy 7,458 $3.36 25,059
Nexvet Biopharma PLC NVET
Ordinary Shares
2016-02-26 Buy 900 $3.36 3,024
Nexvet Biopharma PLC NVET
Ordinary Shares
2016-02-25 Buy 65,694 $3.18 208,907
showing 20 of 163 most recent transactions
Comparable Firms State AUM
Marshall Wace North America LP
NY 58.87 B
Blackstone Private Credit Strategies LLC
NY 57.92 B
TA Associates Management LP
MA 55.07 B
Veritas Capital Fund Management LLC
NY 53.81 B
Blackstone Liquid Credit Advisors I LLC
NY 51.63 B
Crescent Capital Group LP
CA 49.71 B
ICG Investments Inc
NY 49.69 B
Macquarie Infrastructure Partners Inc
NY 48.84 B
Antares Capital Advisers LLC
IL 47.39 B
Silver Point Capital LP
CT 46.23 B
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com